Literature DB >> 17208586

Interrelationships of quantitative asthma-related phenotypes in the Epidemiological Study on the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy.

Marie-Pierre Oryszczyn1, Emmanuelle Bouzigon, Jean Maccario, Valérie Siroux, Rachel Nadif, Anne Wright, Francine Kauffmann.   

Abstract

BACKGROUND: Delineating asthma subphenotypes is of interest to understand the cause of the disease. Few studies have addressed the interrelationships of quantitative asthma-related traits.
OBJECTIVE: We sought to study the interrelationships of allergy markers and FEV(1) in relation to asthma and sex in children and adults.
METHODS: Total IgE levels, skin prick test (SPT) positivity, eosinophil counts, and FEV(1) were assessed in 299 asthmatic cases (children and adults) recruited in chest clinics and 309 nonasthmatic population-based control subjects in the French Epidemiological Study on the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy.
RESULTS: Allergy parameters were significantly higher in asthmatic cases than in control subjects for children and adults and for both sexes. Sex and age modified the pattern of concordance of high IgE levels, SPT positivity, and eosinophilia among asthmatic cases, with the greatest overlap in male children (64%) and the lowest in male adults (18%). Patterns of change over the lifespan of IgE levels, eosinophil counts, and FEV(1)/height(2) varied, with the acceleration of FEV(1) decrease being particularly evident in asthmatic adults. In adult cases and control subjects, SPT positivity (particularly to indoor allergens) was significantly related to IgE levels but not to eosinophil counts. The association of eosinophil counts with IgE levels was evident only in children. Environmental factors (smoking, pets, and country living) did not alter the patterns observed.
CONCLUSIONS: Each allergy-related phenotype showed a distinct relation with asthma, with the role for eosinophils being different than that for IgE levels and SPT responses. CLINICAL IMPLICATIONS: Taking age and sex into account is essential for understanding the interrelationships of the various allergy-related phenotypes to asthma status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17208586     DOI: 10.1016/j.jaci.2006.09.026

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

1.  Air pollution and asthma severity in adults.

Authors:  E Rage; V Siroux; N Künzli; I Pin; F Kauffmann
Journal:  Occup Environ Med       Date:  2008-11-18       Impact factor: 4.402

Review 2.  Asthma: epidemiology, etiology and risk factors.

Authors:  Padmaja Subbarao; Piush J Mandhane; Malcolm R Sears
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

3.  Risk factors associated with asthma phenotypes in dental healthcare workers.

Authors:  Tanusha Singh; Braimoh Bello; Mohamed F Jeebhay
Journal:  Am J Ind Med       Date:  2012-04-02       Impact factor: 2.214

Review 4.  An imbalance in C/EBPs and increased mitochondrial activity in asthmatic airway smooth muscle cells: novel targets in asthma therapy?

Authors:  Michael Roth; Judith L Black
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

5.  Cat sensitization according to cat window of exposure in adult asthmatics.

Authors:  M-P Oryszczyn; R Van Ree; J Maccario; R Nadif; F Kauffmann
Journal:  Clin Exp Allergy       Date:  2009-05-26       Impact factor: 5.018

6.  Evidence for a pleiotropic QTL on chromosome 5q13 influencing both time to asthma onset and asthma score in French EGEA families.

Authors:  Emmanuelle Bouzigon; Ayse Ulgen; Marie-Hélène Dizier; Valérie Siroux; Mark Lathrop; Francine Kauffmann; Isabelle Pin; Florence Demenais
Journal:  Hum Genet       Date:  2007-05-01       Impact factor: 5.881

7.  Asthma and COPD - The C/EBP Connection.

Authors:  Nicola Miglino; Michael Roth; Michael Tamm; Peter Borger
Journal:  Open Respir Med J       Date:  2012-04-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.